RecruitingNot Applicable

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

United States2,996 participantsStarted 2022-06-24

Plain-language summary

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
✓. Patients must have the ability to understand and willingness to provide verbal consent.
✓. Participants must speak English, Spanish, Chinese, or Vietnamese.

Exclusion criteria

✕. Inability to consent to the study
✕. Plans to change oncologist within 12 months
✕. Employed by the practice site
✕. Patients who anticipate moving from the area within 12 months

What they're measuring

Change in health-related quality of life as assessed by the Functional Assessment of Cancer Therapy (FACT-G).

Timeframe: Change in health-related quality of life from baseline to 3 months

Trial details

NCT IDNCT05297734

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-01-31

Contact for this trial

Manali I Patel, MD MPH MS

6507234000 manalip@stanford.edu

View on ClinicalTrials.gov More End of Life trials